tiprankstipranks
Trending News
More News >
Medivir AB (SE:MVIR)
:MVIR

Compare Medivir AB (MVIR) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Medivir AB
kr0.47
kr210.42M
-0.68
-83.43%
0 Buy
0 Hold
0 Sell
Moderate Buy
Isofol Medical AB
€0.05
€17.76M
-1.95
-67.32%
Elicera Therapeutics AB
€0.47
€24.54M
-14.79
81.85%
Ascelia Pharma AB
€0.29
€31.72M
-2.33
-28.51%
IRLAB Therapeutics AB Class A
€0.18
€14.55M
-1.16
-86.40%
Active Biotech AB
€0.01
€10.36M
-3.93
10.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SE:MVIR
Medivir AB
0.47
-2.34
-83.31%
DE:5IU
Isofol Medical AB
0.05
-0.10
-67.32%
DE:8E8
Elicera Therapeutics AB
0.45
0.19
72.14%
DE:7ZA
Ascelia Pharma AB
0.18
-0.07
-29.37%
DE:6IRA
IRLAB Therapeutics AB Class A
0.17
-1.03
-86.24%
DE:BTPC
Active Biotech AB
0.01
0.00
0.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts